CME Group rallies after Q2 profit beat as perpetual future noise remains centerstage

First half of 2026 was the strongest in CME Group's history, CEO Terry Duffy said.

Strong business performance has been overshadowed by discussions surrounding perpetual futures, a CME executive told an analyst, adding it does not substitute for institutional hedging tools.

Exchange stocks have struggled from a combination of a shift in regulatory posture and the perceived threat of perpetual futures, analysts have said.

"We believe the bear case related to perpetual futures will prove to be a non-event for CME, but in the meantime it has created an attractive entry point for CME's shares," Raymond James analyst Patrick O'Shaughnessy said.

"We think the recent lull in trading volumes will prove temporary, higher for longer interest rates is a positive for both interest rate futures trading volumes and interest income."

As of the last close, CME shares were down 13% year to date.

Derivatives exchange major CME Group's CME.O shares jumped 7% to $254.05.

CME said second-quarter profit topped Wall Street expectations as market data revenue hit a record $238 million.